Fenwick & West represented Freenome in the transaction. Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Ursa Major in the transactions. Ursa Major announced its $138 million Series D and D-1 funding rounds. The investments were led by Explorer...
You must be a Standard 1 Year member to access this content.
Fenwick represented Fitch Ventures on the deal. Fitch Ventures, the equity investment arm of Fitch Group, announced its investment in Bixby, a provider of credit information on...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Freenome on the deal. Freenome, a privately held biotechnology company, announced its $300million Series D financing. The round was led by investors Perceptive...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Ursa Major on the deal. Ursa Major, a rocket propulsion company, announced its $85 million Series C financing. The series was led by...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Remitly on the deal. Davis Polk advised several underwriters on the deal. Remitly Global, Inc. (Nasdaq: RELY), a mobile-first provider of remittances...
You must be a Standard 1 Year member to access this content.
